Events3rd International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-3 of the event 3rd International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2017
Citation
Guzmán Ignacio Alvarez, Juan Trinidad, Rafael Fort, Juliette Dourron, Francisco Javier Aguirre, María Ana Duhagon, Searching Bioactive Molecules in Prostate Cancer from Mayan Traditional Medicinal Plants, in Proceedings of 3rd International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2017, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-3-04677
Share
Email
Facebook
Twitter
LinkedIn

Searching Bioactive Molecules in Prostate Cancer from Mayan Traditional Medicinal Plants

image
1. Laboratorio de Moléculas Bioactivas, CENUR Litoral Norte, Universidad de la República, Ruta 3 (km 363), Paysandú, C.P. 60000, Uruguay.
2. Laboratorio de Interacciones Moleculares, Facultad de Ciencias, Universidad de la República, Uruguay.
3. Cuerpo Académico en Ciencias de la Salud y Biotecnología, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Campeche, México.
Abstract

Prostate cancer (PC) is the most common cancer in men around the word. It is a complex and heterogeneous disease in which androgens and their receptor play a crucial role in the progression and development. The current treatment for PC is a combination of surgery, radiation and chemotherapy. Therapeutic agents commonly used in the clinic include steroidal and non- steroidal antiandrogens, such as cyproterone acetate. These few agents have multiple adverse effects and are not 100% effective. Several plant compounds and mixtures, including grape seed polyphenol extracts, lycopene and tomato preparations, soy isoflavones, and green tea extracts, have been shown to be effective against PC cell growth. Some isolated compounds were reported with in vivo activity on CP murine model like capsaicin and curcumin. We prepared a library of plant extracts from traditional Mayan medicine. These plants were selected for their use in the contemporaneous Maya communities with application in different types of diseases and treatments. These extracts were used in a phenotypic screening in LNCaP (androgen sensitive) prostate cancer cells in a fixed dose (25 μg / mL). Ten plants out of 11 were identified with cytotoxic activity in these cells. With the active extracts, a bioguided fractionation method was performed until the elucidation of the major components. We identified 3 compounds with activity and design one hybrid molecule with the natural product structure and steroid analog to enhance the antiproliferative activity.

Keywords
Prostate cancer
LNCaP cell
natural product
Manuscript
Poster
ecmc-3-ppt_cancer_GA2_RF_JT_MAD.pdf
Chiral Liquid Chromatography in Analysis of the Stereochemistry of Marine Natural Compounds: Contribution for Medicinal Chemistry
Antiadenovirus Activity of New Fluorine-containing Polypeptides Mimetics